top of page

Appendix III to the Quality Review of Documents templates for human medicinal products

This appendix should be read together with the Note for Guidance on the Declaration of Storage Conditions A) in the product information of medicinal products, and B) for active substances (EMEA/CPMP/QWP/609/96/Rev 2).

The purpose of the Note for Guidance is to set out uniform statements on storage conditions for inclusion in the product information of medicinal products and labelling of active substances and to define when they apply. The CHMP adopted a revision of this document in November 2007, which resulted in amendments of/or additions to the required storage statements.

Click on this link for more information.

#LegislationRegulatoryAffairs #RegulatoryAffairsHuman

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page